U.S. Autoimmune Disease Diagnostics Market (2024 - 2030) Size, Share & Trends Analysis Report By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics), By Test Type, By End-use, And Segment Forecasts

Market Segmentation

U.S. Autoimmune Disease Diagnostics Type Outlook (Revenue in USD Million, 2018 - 2030)
- Systemic autoimmune disease diagnostics
  - Rheumatoid arthritis
  - Ankylosing spondylitis diagnostics
  - Systemic lupus erythematosus (SLE)
  - Others
- Localized autoimmune disease diagnostics
  - Multiple sclerosis
  - Type 1 diabetes
  - Hashimoto's Thyroiditis
  - Idiopathic thrombocytopenic purpura
  - Others
U.S. Autoimmune Disease Diagnostics Test Type Outlook (Revenue in USD Million, 2018 - 2030)
- Antinuclear antibody tests
- Autoantibody tests
- C-reactive Protein (CRP)
- Complete blood count (CBC)
- Urinalysis
- Others
U.S. Autoimmune Disease Diagnostics End-use Outlook (Revenue in USD Million, 2018 - 2030)
- Hospitals
- Diagnostic centers
- Others
U.S. Autoimmune Disease Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- West
- Midwest
- Northeast
- Southwest
- Southeast

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments